-
Top News: Bellicum Pharmaceuticals (NASDAQ:BLCM), Acasti Pharma Inc. (NASDAQ:ACST), First Financial Corp. (NASDAQ:THFF), Johnson & Johnson (NYSE:JNJ), International Business Machines (NYSE:IBM)
On Friday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $23.02. Bellicum Pharma (NASDAQ:BLCM) announced that clinical results from a study conducted by the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist using the Company’s Caspase-9 safety switch (CaspaCIDe), were simultaneously published in BLOOD and featured…
-
Trader’s Recap: Manitex International (NASDAQ:MNTX), Bellicum Pharmaceuticals (NASDAQ:BLCM), Sinclair Broadcast Group (NASDAQ:SBGI), Bemis Company (NYSE:BMS), Capital Senior Living (NYSE:CSU)
On Friday shares of Manitex International, Inc. (NASDAQ:MNTX) closed at $8.41. Company’s sales growth for last 5 years was 36.40% and EPS growth for next 5 years is recorded as 30.00%. On 11 May, Manitex International, Inc. (NASDAQ:MNTX) swung to a net loss for the quarter ended Mar. 31, 2015. The company has made a…
-
Why Making Dramatic Moves: Royal Caribbean Cruises (NYSE:RCL), Bellicum Pharmaceuticals (NASDAQ:BLCM), Hasbro Inc. (NASDAQ:HAS), AO Smith Corp. (NYSE:AOS), BlackBerry (NASDAQ:BBRY)
On Friday shares of Royal Caribbean Cruises Ltd. (NYSE:RCL) closed at $72.45. Company’s sales growth for last 5 years was 6.50% and EPS growth for next 5 years is recorded as 23.07%. Royal Caribbean Cruises Ltd. (NYSE:RCL) has ordered a fourth Quantum-class ship, slated for delivery in 2019. The agreement with German shipbuilder Meyer Werft…
-
Momentum Stocks: Xerox Corporation (NYSE:XRX), Bellicum Pharmaceuticals (NASDAQ:BLCM), Vitamin Shoppe (NYSE:VSI), Retractable Technologies (NYSEMKT:RVP), Citigroup Inc. (NYSE:C)
On Tuesday shares of Xerox Corporation (NYSE:XRX) closed at $11.55. Company’s sales growth for last 5 years was 5.20% and EPS growth for next 5 years is recorded as 2.00%. Ursula M. Burns, chairman and chief executive officer of Xerox Corporation (NYSE:XRX) will deliver the 2015 Commencement address to Howard University students, faculty, staff, and…
-
Hot News: Bellicum Pharmaceuticals (NASDAQ:BLCM), Goldcorp Inc. (NYSE:GG), World Point Terminals, LP (NYSE:WPT), Convergys (NYSE:CVG), Bright Horizons Family Solutions (NYSE:BFAM)
On Thursday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $23.98. On 29 April, Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) announced it has entered into a license agreement with Leiden University Medical Center (LUMC), Netherlands, for worldwide rights to develop, manufacture and commercialize high-affinity TCR (T cell receptor) product candidates targeting solid tumors expressing the preferentially-expressed antigen…
-
Hot Stocks: Bellicum Pharmaceuticals (NASDAQ:BLCM), Yelp Inc. (NYSE:YELP), Rite Aid Corporation (NYSE:RAD), Microvision Inc. (NASDAQ:MVIS), Tesla Motors Inc (NASDAQ:TSLA)
On Wednesday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $25.71. On 6 April, Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) entered into an amended and restated employment agreement with Annemarie Moseley, Ph.D., M.D. and, the Company entered into an employment agreement with Kevin M. Slawin, M.D. (the “Slawin Employment Agreement”). Yelp Inc. (NYSE:YELP) shares increased 4.14% in…
-
Best Stocks: Bellicum Pharmaceuticals (NASDAQ:BLCM), Samson Oil & Gas Limited (NYSEMKT:SSN), Frontier Communications Corporation (NASDAQ:FTR), Neurocrine Biosciences (NASDAQ:NBIX), Myers Industries (NYSE:MYE)
On Tuesday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $23.17. Bellicum Pharmaceuticals (NASDAQ:BLCM)‘s stock had its “overweight” rating restated by stock analysts at Piper Jaffray in a report issued on Friday. They currently have a $45.00 target price on the stock. Piper Jaffray’s price objective suggests a potential upside of 100.36% from the company’s…
-
5 Active Stocks: Bellicum Pharmaceuticals (NASDAQ:BLCM), CollabRx (NASDAQ:CLRX), Bloomin’ Brands (NASDAQ:BLMN), Canadian Pacific Railway Limited (NYSE:CP), EverBank Financial (NYSE:EVER)
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), announced that management presented at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11, 2015 in New York City.On Thursday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $22.34. CollabRx, Inc. (NASDAQ:CLRX) announced the pricing of an underwritten public offering of 3,840,000 shares of its common stock and warrants to…
-
Top Morning News: IntelliPharmaCeutics International Inc. (NASDAQ:IPCI), Bellicum Pharmaceuticals (NASDAQ:BLCM), Aeropostale (NYSE:ARO), Brunswick Corporation (NYSE:BC), Affiliated Managers Group Inc. (NYSE:AMG)
Analysts at Zacks have given a Neutral rating on IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) with a rating of 3. The counter has received an average rating of 1.43 from 3 brokerage firms. On Friday shares of IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) closed at $2.03. Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) has completed dosing in the first cohort of…
-
Must Watch These 5 Stocks: Bellicum Pharmaceuticals (NASDAQ:BLCM), Hertz Global Holdings (NYSE:HTZ), Donaldson Company (NYSE:DCI), Oracle (NYSE:ORCL), Cumulus Media (NASDAQ:CMLS)
On January 14, Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) has completed dosing in the first cohort of patients in the BP-004 Phase I/II trial with its genetically engineered donor T cells (BPX-501), after receiving a partial T depleted haplo-identical allogeneic hematopoietic stem cell transplant (haplo-HSCT). On Friday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $24.12. On…